The Food and Drug Administration authorized the emergency use of the drug remdesivir in Covid-19 patients after researchers reported that it shortened the recovery times in people who have fallen ill from the new coronavirus.
The FDA action limits the use of the drug, produced by Gilead Sciences Inc., for only through the duration of the pandemic, but health regulators could grant full approval if more benefits emerge from a large study by the National Institute of Allergy and Infectious Diseases and other clinical trials under way.
Link:- https://www.google.co.in/amp/s/www.wsj.com/amp/articles/fda-authorizes-emergency-use-of-gilead-drug-for-covid-19-patients-11588363751
No comments:
Post a Comment